Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291169 · ClinicalTrials.gov registry record · NA
Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers
A NA study of Venous Leg Ulcer, sponsored by Omeza.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 7
- Study locations
NCT05291169 is a NA study of Venous Leg Ulcer that has completed, run by Omeza. The registered enrollment target is 54 participants, below the 243-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (78% lower). The trial reports 7 study locations across 4 states.
The verdict
NCT05291169, a NA study of Venous Leg Ulcer, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 7
- Study locations
Study Summary
A Randomized, Multicenter, Open Label Study Comparing Omeza Combination Therapy with Standard of Care to Standard of Care alone for Chronic Venous Leg Ulcers over the course of 4 weeks
Conditions Studied
Interventions
- DEVICE Omeza® OCM™
Study Locations (7)
Pennsylvania
- The Foot and Ankle Wellness Center of Western Pennsylvania - Ford City
- ACMH Wound Clinic - Kittanning
- Serena Group - Monroeville
Florida
- Royal Research, Corp - Hollywood
- Three Rivers Wound and Hyperbaric Center - North Port
California
- New Hope Podiatry - Los Angeles
Oklahoma
- Wound Care of Tulsa - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05291169
The ClinicalTrials.gov registry entry for NCT05291169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (78% lower). The listed sponsor is Omeza, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Omeza® OCM™ is the first listed.
NCT05291169 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Pennsylvania, Florida, California.
Frequently Asked Questions
What is clinical trial NCT05291169 about?
NCT05291169 is a clinical study titled "Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers". A Randomized, Multicenter, Open Label Study Comparing Omeza Combination Therapy with Standard of Care to Standard of Care alone for Chronic Venous Leg Ulcers over the course of 4 weeks
What is the current status of trial NCT05291169?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2022-04-11. Estimated completion is 2024-03-01.
What conditions does trial NCT05291169 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT05291169?
The interventions under investigation include: Omeza® OCM™ (DEVICE).
Who is sponsoring clinical trial NCT05291169?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05291169 being conducted?
This trial has 7 study locations across California, Florida, Oklahoma, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.